MedPath

Essenlix Corporation

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Clinical Evaluation of the iMOST-X1 Hematology Analyzer - Matrix Study

Completed
Conditions
Hematologic Tests
First Posted Date
2021-03-03
Last Posted Date
2021-03-03
Lead Sponsor
Essenlix Corporation
Target Recruit Count
60
Registration Number
NCT04778553
Locations
🇺🇸

Hunterdon Medical Center, Flemington, New Jersey, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.